These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 33270896

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A Multi-omic Association Study of Trimethylamine N-Oxide.
    Manor O, Zubair N, Conomos MP, Xu X, Rohwer JE, Krafft CE, Lovejoy JC, Magis AT.
    Cell Rep; 2018 Jul 24; 24(4):935-946. PubMed ID: 30044989
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
    Canyelles M, Borràs C, Rotllan N, Tondo M, Escolà-Gil JC, Blanco-Vaca F.
    Int J Mol Sci; 2023 Jan 18; 24(3):. PubMed ID: 36768264
    [Abstract] [Full Text] [Related]

  • 28. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
    Li W, Huang A, Zhu H, Liu X, Huang X, Huang Y, Cai X, Lu J, Huang Y.
    Med J Aust; 2020 Oct 18; 213(8):374-379. PubMed ID: 32959366
    [Abstract] [Full Text] [Related]

  • 29. Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease.
    He W, Luo Y, Liu JP, Sun N, Guo D, Cui LL, Zheng PP, Yao SM, Yang JF, Wang H.
    Clin Interv Aging; 2020 Oct 18; 15():1809-1820. PubMed ID: 33061331
    [Abstract] [Full Text] [Related]

  • 30. Modulation of Circulating Trimethylamine N-Oxide Concentrations by Dietary Supplements and Pharmacological Agents: A Systematic Review.
    Kalagi NA, Abbott KA, Alburikan KA, Alkofide HA, Stojanovski E, Garg ML.
    Adv Nutr; 2019 Sep 01; 10(5):876-887. PubMed ID: 31073588
    [Abstract] [Full Text] [Related]

  • 31. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
    Tang WH, Hazen SL.
    Transl Res; 2017 Jan 01; 179():108-115. PubMed ID: 27490453
    [Abstract] [Full Text] [Related]

  • 32. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C, Rattanawong P, Charoensri S, Senthong V.
    Curr Nutr Rep; 2018 Dec 01; 7(4):207-213. PubMed ID: 30362023
    [Abstract] [Full Text] [Related]

  • 33. Plasmatic trimethylamine N-oxide and its relation to stroke: A systematic review and dose-response meta-analysis.
    Chen P, Guo Z.
    Medicine (Baltimore); 2022 Jul 22; 101(29):e29512. PubMed ID: 35866835
    [Abstract] [Full Text] [Related]

  • 34. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort.
    Senthong V, Kiatchoosakun S, Wongvipaporn C, Phetcharaburanin J, Sritara P, Phrommintikul A, CORE Investigators.
    Sci Rep; 2024 Sep 11; 14(1):21264. PubMed ID: 39261513
    [Abstract] [Full Text] [Related]

  • 35. Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function.
    Canyelles M, Tondo M, Cedó L, Farràs M, Escolà-Gil JC, Blanco-Vaca F.
    Int J Mol Sci; 2018 Oct 19; 19(10):. PubMed ID: 30347638
    [Abstract] [Full Text] [Related]

  • 36. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.
    Nie J, Xie L, Zhao BX, Li Y, Qiu B, Zhu F, Li GF, He M, Wang Y, Wang B, Liu S, Zhang H, Guo H, Cai Y, Huo Y, Hou FF, Xu X, Qin X.
    Stroke; 2018 Sep 19; 49(9):2021-2028. PubMed ID: 30354996
    [Abstract] [Full Text] [Related]

  • 37. Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease.
    Thomas MS, Fernandez ML.
    Curr Atheroscler Rep; 2021 Feb 17; 23(4):12. PubMed ID: 33594574
    [Abstract] [Full Text] [Related]

  • 38. Circulating TMAO, the gut microbiome and cardiometabolic disease risk: an exploration in key precursor disorders.
    Naghipour S, Cox AJ, Fisher JJ, Plan M, Stark T, West N, Peart JN, Headrick JP, Du Toit EF.
    Diabetol Metab Syndr; 2024 Jun 17; 16(1):133. PubMed ID: 38886825
    [Abstract] [Full Text] [Related]

  • 39. Impact of probiotic supplementation on trimethylamine N-oxide (TMAO) in humans: A systematic review and meta-analysis of randomized controlled trials.
    Sohouli MH, Ozovanu OD, Fatahi S, Hekmatdoost A.
    Clin Nutr ESPEN; 2022 Aug 17; 50():56-62. PubMed ID: 35871952
    [Abstract] [Full Text] [Related]

  • 40. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
    Nowiński A, Ufnal M.
    Nutrition; 2018 Feb 17; 46():7-12. PubMed ID: 29290360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.